Priyank J. Shah

Array ( [id] => 6697476 [patent_doc_number] => 20030109670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Cone snail peptides' [patent_app_type] => new [patent_app_number] => 10/072602 [patent_app_country] => US [patent_app_date] => 2002-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21587 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109670.pdf [firstpage_image] =>[orig_patent_app_number] => 10072602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1137677 [patent_doc_number] => 06780614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-24 [patent_title] => 'Modified factor VIII cDNA and its use for the production of factor VIII' [patent_app_type] => B2 [patent_app_number] => 10/067894 [patent_app_country] => US [patent_app_date] => 2002-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4193 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780614.pdf [firstpage_image] =>[orig_patent_app_number] => 10067894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536181 [patent_doc_number] => 20020193302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Use of FVIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis' [patent_app_type] => new [patent_app_number] => 10/051044 [patent_app_country] => US [patent_app_date] => 2002-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12872 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193302.pdf [firstpage_image] =>[orig_patent_app_number] => 10051044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034171 [patent_doc_number] => 20050032681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'HUMAN ANTITHROMBIN IIIS AND METHODS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 10/014658 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17546 [patent_no_of_claims] => 138 [patent_no_of_ind_claims] => 46 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032681.pdf [firstpage_image] =>[orig_patent_app_number] => 10014658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923964 [patent_doc_number] => 20020115833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Erythropoietin conjugates' [patent_app_type] => new [patent_app_number] => 10/014363 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9656 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115833.pdf [firstpage_image] =>[orig_patent_app_number] => 10014363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7290742 [patent_doc_number] => 20040110675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Mutant human factor ix with an increased resistance to inhibition by heparin' [patent_app_type] => new [patent_app_number] => 10/416952 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20530 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110675.pdf [firstpage_image] =>[orig_patent_app_number] => 10416952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7313390 [patent_doc_number] => 20040033566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Modified factor viia' [patent_app_type] => new [patent_app_number] => 10/415963 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7902 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033566.pdf [firstpage_image] =>[orig_patent_app_number] => 10415963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1134750 [patent_doc_number] => 06784154 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-31 [patent_title] => 'Method of use of erythropoietin to treat ischemic acute renal failure' [patent_app_type] => B2 [patent_app_number] => 10/003352 [patent_app_country] => US [patent_app_date] => 2001-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6094 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/784/06784154.pdf [firstpage_image] =>[orig_patent_app_number] => 10003352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874587 [patent_doc_number] => 20020049161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Pharmaceutical combination preparations containing erythropoietin and iron preparations' [patent_app_type] => new [patent_app_number] => 09/984268 [patent_app_country] => US [patent_app_date] => 2001-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6592 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049161.pdf [firstpage_image] =>[orig_patent_app_number] => 09984268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1082970 [patent_doc_number] => 06833352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-21 [patent_title] => 'Coagulation factor Viia composition' [patent_app_type] => B2 [patent_app_number] => 10/026032 [patent_app_country] => US [patent_app_date] => 2001-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 2 [patent_no_of_words] => 5978 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/833/06833352.pdf [firstpage_image] =>[orig_patent_app_number] => 10026032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6544510 [patent_doc_number] => 20020137673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Factor VII glycoforms' [patent_app_type] => new [patent_app_number] => 09/969357 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10999 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137673.pdf [firstpage_image] =>[orig_patent_app_number] => 09969357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6472824 [patent_doc_number] => 20020151471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Factor VII glycoforms' [patent_app_type] => new [patent_app_number] => 09/969358 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10917 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151471.pdf [firstpage_image] =>[orig_patent_app_number] => 09969358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6032861 [patent_doc_number] => 20020019036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-14 [patent_title] => 'Von willebrand factor derivatives and methods of isolating proteins that bind to von willebrand factor' [patent_app_type] => new [patent_app_number] => 09/967937 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5216 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20020019036.pdf [firstpage_image] =>[orig_patent_app_number] => 09967937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1151379 [patent_doc_number] => 06770744 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-03 [patent_title] => 'Modified factor VIII' [patent_app_type] => B2 [patent_app_number] => 09/957641 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 22770 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770744.pdf [firstpage_image] =>[orig_patent_app_number] => 09957641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6650970 [patent_doc_number] => 20030104996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'L-methionine as a stabilizer for NESP/EPO in HSA-free formulations' [patent_app_type] => new [patent_app_number] => 09/945517 [patent_app_country] => US [patent_app_date] => 2001-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5258 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104996.pdf [firstpage_image] =>[orig_patent_app_number] => 09945517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6561230 [patent_doc_number] => 20020164739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Cell calcification supressing proteins, and genes of the proteins' [patent_app_type] => new [patent_app_number] => 09/902772 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5273 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164739.pdf [firstpage_image] =>[orig_patent_app_number] => 09902772 [rel_patent_id] =>[rel_patent_doc_number] =>)